<DOC>
	<DOCNO>NCT00760578</DOCNO>
	<brief_summary>The purpose study determine MSDC-0160 effective treatment Type 2 diabetes .</brief_summary>
	<brief_title>A Placebo Controlled Safety Efficacy Study MSDC-0160 Type 2 Diabetes With Active Comparator</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Diagnosis Type 2 Diabetes naive metformin Male female ( postmenopausal surgically sterilize ) , 18 70 year age . Use diabetes medication metformin . History heart failure previous myocardial infarction . Blood pressure great 160/100 mmHg .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>